Tsao AS - Search Results

1

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.

Riely GJ, Neal JW, Camidge DR, Spira AI, Piotrowska Z, Costa DB, Tsao AS, Patel JD, Gadgeel SM, Bazhenova L, Zhu VW, West HL, Mekhail T, Gentzler RD, Nguyen D, Vincent S, Zhang S, Lin J, Bunn V, Jin S, Li S, Jänne PA. Riely GJ, et al. Among authors: tsao as. Cancer Discov. 2021 Jul;11(7):1688-1699. doi: 10.1158/2159-8290.CD-20-1598. Epub 2021 Feb 25. Cancer Discov. 2021. PMID: 33632775 Free PMC article. Clinical Trial.

2

Imatinib mesylate causes hypopigmentation in the skin.

Tsao AS, Kantarjian H, Cortes J, O'Brien S, Talpaz M. Tsao AS, et al. Cancer. 2003 Dec 1;98(11):2483-7. doi: 10.1002/cncr.11812. Cancer. 2003. PMID: 14635084 Free article.

3

Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.

Tsao AS, Shin DM, Palmer JL, Lee JS, Glisson BS. Tsao AS, et al. Cancer. 2004 May 15;100(10):2240-5. doi: 10.1002/cncr.20238. Cancer. 2004. PMID: 15139070 Free article. Clinical Trial.

4

Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Tsao AS, et al. Cancer. 2006 Jun 1;106(11):2428-36. doi: 10.1002/cncr.21884. Cancer. 2006. PMID: 16634096 Free article.

5

Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.

Thomas SK, Fossella FV, Liu D, Schaerer R, Tsao AS, Kies MS, Pisters KM, Blumenschein GR Jr, Glisson BS, Lee JJ, Herbst RS, Zinner RG. Thomas SK, et al. Among authors: tsao as. Clin Lung Cancer. 2006 Mar;7(5):326-31. doi: 10.3816/CLC.2006.n.014. Clin Lung Cancer. 2006. PMID: 16640804

6

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

Tsao AS, Tang XM, Sabloff B, Xiao L, Shigematsu H, Roth J, Spitz M, Hong WK, Gazdar A, Wistuba I. Tsao AS, et al. J Thorac Oncol. 2006 Mar;1(3):231-9. doi: 10.1016/s1556-0864(15)31573-2. J Thorac Oncol. 2006. PMID: 17409862 Free article.

7

Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.

Tsao AS, Wei W, Kuhn E, Spencer L, Solis LM, Suraokar M, Lee JJ, Hong WK, Wistuba II. Tsao AS, et al. Clin Lung Cancer. 2011 Nov;12(6):369-74. doi: 10.1016/j.cllc.2011.02.002. Epub 2011 May 17. Clin Lung Cancer. 2011. PMID: 21729646 Free PMC article.

8

Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.

Tsao AS, Liu S, Fujimoto J, Wistuba II, Lee JJ, Marom EM, Charnsangavej C, Fossella FV, Tran HT, Blumenschein GR, Papadimitrakopoulou V, Kies MS, Hong WK, Stewart DJ. Tsao AS, et al. J Thorac Oncol. 2011 Dec;6(12):2104-11. doi: 10.1097/JTO.0b013e31822e7256. J Thorac Oncol. 2011. PMID: 21892101 Free article. Clinical Trial.

9

Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman M, Gandara DR. Garland LL, et al. Among authors: tsao as. J Thorac Oncol. 2011 Nov;6(11):1938-45. doi: 10.1097/JTO.0b013e318229586e. J Thorac Oncol. 2011. PMID: 21964533 Free PMC article. Clinical Trial.

10

Mesothelioma and small cell lung cancer.

Tsao AS, Heymach J. Tsao AS, et al. J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1825-6. doi: 10.1097/01.JTO.0000407574.52702.92. J Thorac Oncol. 2011. PMID: 22005546 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page